Similar drugsTo uncover Dosage form: & nbsppastilles anisovo-licorice, orange, honey-lemon, eucalyptus-menthol Composition:1 loaf of NOVOSEPT® FORTE of any taste contains:Active substances:Cetylpyridinium chloride 1.50 mg(in terms of cetylpyridinium chloride monohydrate - 1.58 mg)Tetracaine hydrochloride 0.10 mg Zinc sulfate heptahydrate 13.30 mgExcipients NOVOSEPT® FORTE pastilles anisovo-licorice: sucrose 1426.10 mg, dextrose syrup 932.00 mg, herb extract * 25.00 mg, tartaric acid 25.00 mg, anethole 3.50 mg, levomentol 1.30 mg, eucalyptus oil 1.30 mg, dye caramel "E-150 d 7.20 mg, flavor" anise "0.70 mg, water purified 63.00 mg.* Extract obtained from plant parts: licorice root, lanceolate leaves, raspberry leaves, mint leaves, chamomile flowers, eucalyptus leaves, fennel, elderberry flowers, Icelandic moss, flowers and cups of cornflower, linden flowers, medinitsa, mallow flowers, flowers and Calendula calyx, sage leaves, yarrow flowers, primrose flowers and cups, star anise, thyme, mullein flowers.Auxiliaries NOVOSEPT® FORTE pastilles are orange: sucrose 1435.20 mg, dextrose syrup 940.00 mg, tartaric acid 37.00 mg, dye sunset yellow E 110 0.20 mg, orange flavor 9.70 mg, water purified 63.00 mg. Auxiliaries NOVOSEPT® FORTE pastilles honey-lemon: sucrose 1422.00 mg, dextrose syrup 932.00 mg, tartaric acid 32.00 mg, honey 30.00 mg, mint oil 4.37 mg, lemon oil 0.03 mg, dye quinoline yellow E 104 0.20 mg, flavoring "honey" 1.50 mg, water purified 63.00 mg.Auxiliaries NOVOSEPT® FORTE eucalyptus-menthol troches: sucrose 1439.80 mg, dextrose syrup 945.00 mg, tartaric acid 26.00 mg, levomentol 4.50 mg, eucalyptus oil 4.50 mg, indigo carmine dye E 132 2.30 mg, water purified 63.00 mg. Description:Anisovo-licorice pastilles: flat round, with a bevelled edge of a lozenge with a rough surface, brown with a specific odor. Allowed uneven staining, the presence of air bubbles in the caramel mass and a slight unevenness of the edges.Orange pastilles: flat round, with a bevelled edge of a lozenge with a rough surface, orange with a specific smell. Allowed uneven staining, the presence of air bubbles in the caramel mass and a slight unevenness of the edges.Pastilles honey-lemon: flat round, with a bevelled edge of a lozenge with a rough surface, yellow with a specific odor.Allowed uneven staining, the presence of air bubbles in the caramel mass and a slight unevenness of the edges.Eucalyptus-menthol pastilles: flat round, with a bevelled edge of a lozenge with a rough surface, a greenish-blue with a whitish shade of color with a specific smell. Allowed uneven staining, the presence of air bubbles in the caramel mass and a slight unevenness of the edges. Pharmacotherapeutic group:antiseptic and topical anesthetic ATX: & nbspOther preparations for topical use in diseases of the oral cavity Pharmacodynamics:NOVOSEPT® FORTE possesses a bactericidal, antifungal, and local anesthetic effect due to its active components:-Cetylpyridinium chloride-antiseptic. Has a bactericidal action against a wide range of gram-positive and, to a lesser extent, gram-negative bacteria. The antimicrobial activity of cetylpyridinium chloride is due to its non-specific interaction with various components of the bacterial cell: membrane, ribosomes, proteins and enzymes, as a result of which osmotic equilibrium, respiration,carbohydrate and protein metabolism, and all this leads to the death of the bacteria. Cetylpyridinium chloride also suppresses some groups of viruses and fungi.-Tetracaine is an effective local anesthetic, quickly relieves or reduces the sensation of pain.Zinc sulfate is a microelement that exerts an immunostimulating effect. Indications:Local treatment of inflammation of the mucous membranes of the oral cavity and pharynx: stomatitis, gingivitis, tonsillitis, pharyngitis. Contraindications:Hypersensitivity to drug components, local anesthetics, mucosal integrity disorder, acute renal or hepatic insufficiency, sugarase / isomaltase deficiency, fructose intolerance, glucose-galactose malabsorption.Pregnancy, lactation, children's age (under 18 years). Carefully:Diabetes. Dosing and Administration:Locally. Keep in the mouth until completely absorbed, without chewing.Adults: 1 lozenge 4-6 times a day with an interval of 2 hours.The course of treatment is no more than five days. Side effects:Allergic reactions, swallowing, numbness of the tongue are possible. Overdose:Given the amount of active substance contained in a single lozenge, the possibility of an overdose is minimal. Taking doses that are higher than recommended can cause disturbances in the gastrointestinal tract: nausea, vomiting and diarrhea. In this case, stop taking the medication and consult a doctor.Treatment: gastric lavage, the appointment of salt laxatives; symptomatic therapy. Interaction:Lozenges should not be taken with milk, as it reduces the antimicrobial activity of cetylpyridinium chloride.Tetracaine reduces the antibacterial activity of sulfanilamide preparations. Vasoconstrictors extend the effect and reduce the toxicity of tetracaine. Zinc salts reduce the effect of penicillamine, form chelates with tetracycline. Special instructions:If the disease is accompanied by an increase in body temperature, headache, nausea, and also if there is no improvement within five days from the beginning of treatment, you should see a doctor.Long-term treatment (more than 5 days) can cause a disturbance in the balance of the natural microflora of the oral cavity and pharynx with the risk of developing pathogenic bacteria and fungi.Indication for patients with diabetes: one lozenge contains 1.4 g of sucrose (0.12 XE). Form release / dosage:Pastilles anisovo-licorice, orange, honey-lemon, eucalyptus-menthol. Packaging:For 2, 4, 6, 8, 10, 12 lozenges in a PVC / A1 blister. For 1, 2, 3, 4, 5 blisters with instructions for use in a cardboard bundle. Storage conditions:At a temperature of no higher than 25 ° C. Shelf life:3 years.Do not use after the expiration date. Terms of leave from pharmacies:Without recipe Registration number:LS-000729 Date of registration:23.06.2010 / 29.04.2014 The owner of the registration certificate:VALEANT, LLC VALEANT, LLC Russia Manufacturer: & nbspVALEANT, LLC Russia Information update date: & nbsp2016-01-28 Illustrated instructions × Illustrated instructions Instructions